Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Uru Nezu Osada"'
Autor:
Tomoaki Akiyama, Tadashi Yamakawa, Kazuki Orime, Jun Suzuki, Rika Sakamoto, Minori Matsuura‐Shinoda, Erina Shigematsu, Kenichiro Takahashi, Mizuki Kaneshiro, Taro Asakura, Shunichi Tanaka, Takehiro Kawata, Yoshihiko Yamada, Tetsuo Isozaki, Atsushi Takahashi, Uru Nezu Osada, Kazuaki Kadonosono, Yasuo Terauchi
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 5, Pp 716-724 (2023)
ABSTRACT Aims/Introduction We carried out a cross‐sectional study of people with type 2 diabetes mellitus to elucidate the association between sleep duration and food intake. Materials and Methods Overall, 2,887 participants with type 2 diabetes me
Externí odkaz:
https://doaj.org/article/df51490370534835afcde1e8cb4ae60e
Autor:
Tadashi Yamakawa, Rika Sakamoto, Kenichiro Takahashi, Jun Suzuki, Minori Matuura‐Shinoda, Mayumi Takahashi, Erina Shigematsu, Shunichi Tanaka, Mizuki Kaneshiro, Taro Asakura, Takehiro Kawata, Yoshihiko Yamada, Uru Nezu Osada, Tetsuo Isozaki, Atsushi Takahashi, Kazuaki Kadonosono, Yasuo Terauchi
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 2, Pp 309-317 (2019)
Abstract Aims/Introduction The present study investigated the relationship between the macronutrient energy ratio, dietary carbohydrate and glycated hemoglobin levels in Japanese patients with type 2 diabetes, to generate a potential optimal dietary
Externí odkaz:
https://doaj.org/article/8ea76ada5d514542820d37d0f22e1fb4
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0154821 (2016)
We investigated the association between common type 2 susceptibility variants of CDK5 regulatory subunit associated protein 1-like 1(CDKAL1) and therapeutic responses to anti-diabetic agents among patients with type 2 diabetes. Two SNPs (rs7754840: C
Externí odkaz:
https://doaj.org/article/cbac1ed9affb4386bcc49e990daaab6b
Autor:
Tetsuo Isozaki, Erina Shigematsu, Mizuki Kaneshiro, Yoshihiko Yamada, Atsushi Takahashi, Uru Nezu Osada, Minori Matsuura-Shinoda, Taro Asakura, Rika Sakamoto, Masahiro Ichikawa, Tadashi Yamakawa, Jun Suzuki, Takehiro Kawata, Shun-ichi Tanaka, Yasuo Terauchi, Kazuaki Kadonosono, Kenichiro Takahashi
Publikováno v:
Endocrine journal. 69(4)
This study aimed to reveal the relationship between quality of life (QOL) and sleep quality in patients with type 1 diabetes mellitus (T1DM). Overall, 202 patients with T1DM were registered in our study, and 192 were eligible for analysis. Baseline c
Autor:
Yoshinobu Kondo, Masaaki Hanaoka, Taku Yamada, Toshihiro Misumi, Yuzuru Ito, Saho Hosokawa, Kazuki Orime, Tomoko Shibasaki-Kurita, Kengo Azushima, Taishi Yoshii, Jun Yutoh, Kazutaka Aoki, Tadashi Yamakawa, Uru Nezu Osada, Takayuki Yamada, Sho Kinguchi, Hiromichi Wakui, Kohji Inazumi, Ryu Kobayashi, Yasuo Terauchi, Kotaro Haruhara, Yusuke Kobayashi, Hiroto Sasaki, Syuji Ono, Takeharu Yamanaka, Tamio Iwamoto, Gen Yasuda, Kouichi Tamura, Kohji Ohki
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-16 (2019)
Cardiovascular Diabetology
Cardiovascular Diabetology
BackgroundThe Y-AIDA study was designed to investigate the renal- and home blood pressure (BP)-modulating effects of add-on dapagliflozin treatment in Japanese individuals with type 2 diabetes mellitus (T2DM) and albuminuria.MethodsWe conducted a pro
Autor:
Kenichiro Takahashi, Taro Asakura, Tetsuo Isozaki, Mizuki Kaneshiro, Erina Shigematsu, Jun Suzuki, Shun-ichi Tanaka, Uru Nezu Osada, Yoshihiko Yamada, Yasuo Terauchi, Kazuaki Kadonosono, Atsushi Takahashi, Rika Sakamoto, Mayumi Takahashi, Takehiro Kawata, Tadashi Yamakawa, Minori Matuura-Shinoda
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 2, Pp 309-317 (2019)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction The present study investigated the relationship between the macronutrient energy ratio, dietary carbohydrate and glycated hemoglobin levels in Japanese patients with type 2 diabetes, to generate a potential optimal dietary intake of
Autor:
Takeharu Yamanaka, Yuzuru Ito, Tadashi Yamakawa, Taishi Yoshii, Jun Yutoh, Kotaro Haruhara, Tamio Iwamoto, Uru Nezu Osada, Kouichi Tamura, Yoshinobu Kondo, Kengo Azushima, Toshihiro Misumi, Sho Kinguchi, Hiromichi Wakui, Gen Yasuda, Yusuke Kobayashi, Yasuo Terauchi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
We investigated the impact of basal dietary sodium intake on the dapagliflozin-induced changes in albuminuria and blood pressure (BP) measured at home in patients with diabetic kidney disease (DKD).This was a secondary analysis of the Y-AIDA Study, i
Autor:
Yulia Namiki, Hiroto Sasaki, Tomoyuki Iwasaki, Hikaru Takamine, Taichi Minami, Naoki Mantani, Eiji Yamada, Uru Nezu Osada, Yuya Takano, Koji Inazumi, Satoshi Ito, Masayo Yamada, Atsushi Nakajima, Yasuo Terauchi
Publikováno v:
Journal of Gastroenterology and Hepatology. 33:863-868
Background and Aim Changes in treatment protocols for patients with diabetes mellitus (DM) may influence the functions of the digestive tract. This study examined possible clinical factors associated with the symptoms of constipation in patients with
Autor:
Masahiro Ichikawa, Tadashi Yamakawa, Rika Sakamoto, Kenichiro Takahashi, Jun Suzuki, Minori Matsuura-Shinoda, Erina Shigematsu, Shunichi Tanaka, Mizuki Kaneshiro, Taro Asakura, Takehiro Kawata, Yoshihiko Yamada, Uru Nezu Osada, Tetsuo Isozaki, Atsushi Takahashi, Kazuaki Kadonosono, Yasuo Terauchi
Publikováno v:
Endocrine Journal; 2022, Vol. 69 Issue 4, p399-406, 8p
Autor:
Makiko Mieno, Toshimasa Yamauchi, Yuya Tsurutani, Uru Nezu Osada, Akiko Sankoda, Masaomi Nangaku, Akihiro Isogawa, Yuki Kawai, Taichi Minami, Aki Hayashi, Shiro Komiya, Yasuo Terauchi, Nobuhito Hirawa, Hiromichi Wakui, Tamio Iwamoto, Tatsuro Takano, Kazuhiko Ohe, Kayo Waki, Kana Miyake, Tadashi Yamakawa, Jun Saito, Shinobu Satoh, Takashi Kadowaki, Kouichi Tamura, Naoki Kashihara
Publikováno v:
JMIR Research Protocols
Background Diabetic kidney disease (DKD) is one of the main complications of type 2 diabetes mellitus (T2DM). DKD is a known risk factor for end-stage renal disease, cardiovascular disease, and all-cause death. Effective intervention for early-stage